Diagnosing and treating elite and Olympic athletes with exercise-induced bronchoconstriction (EIB) has been well established. However, a sub-set of elite and Olympic athletes with exercise-induced bronchoconstriction experience symptoms of breathlessness due to lack of adherence, improper medications, and/or generalized breathing dysfunction. A short review of traditional treatment plans for elite and Olympic athletes is presented along with the challenges of adherence, managing dysfunctional breathing, and measuring and treating mental skills deficits. Elite and Olympic athletes may not respond to traditional treatment for exercise-induced bronchospasm and we present some of the reasons why the athletes fail to respond. Furthermore, we present information on how to detect and treat elite and Olympic athletes with difficult to treat asthma. As part of this review we developed a flow diagram for medical providers to identify the reasons for lack of response to traditional treatment plans for exercise-induced bronchoconstriction with options on other treatment modalities.Copyright © 2020. Published by Elsevier Inc.
Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.
April 28, 2020
Psychosocial risk factors and outcomes associated with suicide attempts in childhood: A retrospective study.
April 12, 2020
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.
January 7, 2021
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.